Dendrite Appoints Carl L. Cohen as President of Marketing Solutions
29 Juin 2006 - 5:20PM
Business Wire
Dendrite International, Inc. (NASDAQ:DRTE) a leading provider of
pharmaceutical industry solutions, today announced the appointment
of Carl L. Cohen as President of its Marketing Solutions division.
Mr. Cohen is an integral addition to Dendrite's new management team
and will be responsible for driving this rapidly growing division.
Mr. Cohen joins Dendrite from Starwood Hotels and Resorts
Worldwide, one of the largest hotel chains in the world, where he
most recently served as Senior Vice President. Mr. Cohen held
several strategic positions during his tenure at Starwood,
including running its software and services division and starting a
profitable broadband business unit. He also led many crucial
initiatives, notably the creation of a new reservation and loyalty
marketing system for the hotel chain. Previously, Mr. Cohen served
as Chief Marketing Officer at Wrenchhead.com and Executive Vice
President of Marketing for Championship Auto Racing Teams, a global
brand in auto sports. During his career, Mr. Cohen has held several
senior marketing and brand management leadership positions at
companies such as Philip Morris, Colgate Palmolive and Reckitt
& Coleman. "Based on the products and services available today
and those coming in the future, the Marketing Solutions division at
Dendrite is poised for explosive growth on a global scale," said
Mr. Cohen. "The opportunity to join Dendrite at this exciting time,
to help lead this innovative division, was one that I could not
resist." "Carl will bring a fresh perspective to Dendrite from a
successful career that has spanned more than 20 years in a wide
range of industries," said Joseph Ripp, president and COO of
Dendrite. "We're looking forward to Carl's contributions, including
spearheading the kind of new thinking and approaches that will be
instrumental to Dendrite as we continue to forge a leadership
path." Mr. Cohen is a graduate of SUNY at Albany and earned his
Master's of Business Administration from The Wharton School of the
University of Pennsylvania. About Dendrite Founded in 1986,
Dendrite International (NASDAQ: DRTE) enables sales, marketing,
clinical and compliance solutions for the global pharmaceutical
industry. The Company's clients are located in more than 50
countries and include the world's top 20 pharmaceutical companies.
For more information, please visit www.dendrite.com. Note: Dendrite
is a registered trademark of Dendrite International, Inc. This
document may contain forward-looking statements that may be
identified by such forward-looking terminology as "expect,"
"believe," "anticipate," "will," "intend," "plan," "target,"
"outlook," "guidance," and similar statements or variations. Such
forward-looking statements are based on our current expectations,
estimates, assumptions and projections and involve significant
risks and uncertainties, including risks which may result from our
dependence on the pharmaceutical industry; fluctuations in
quarterly revenues due to lengthy sales and implementation cycles
for certain of our solutions; our fixed expenses in relation to
fluctuating revenues and variations in customers' budget cycles;
dependence on certain major customers; changes in demand for our
products and services attributable to any weakness experienced in
the economy or mergers, acquisitions and consolidations in the
pharmaceutical industry; successful and timely development and
introduction of new products and versions; rapid technological
changes; increased competition; international operations;
integrating the entities we acquire; our ability to effectively
manage our growth; the protection of our proprietary technology;
our ability to compete in the Internet-related products and
services market; the continued demand for Internet-related products
and services; the ability of our third party vendors to respond to
technological change; our ability to maintain our relationships
with third-party vendors; less favorable than anticipated results
from strategic relationships; dependence of data solutions on
strategic relationships; events which may affect the U.S. and world
economies; and catastrophic events which could negatively affect
our information technology infrastructure. Other important factors
that should be reviewed and carefully considered are included in
the company's 10-K, 10-Qs, and other reports filed with the SEC.
Actual results may differ materially. The company assumes no
obligation for updating any such forward-looking statements to
reflect actual results, changes in assumptions or other changes
affecting such forward-looking statements.
Dendrite (NASDAQ:DRTE)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Dendrite (NASDAQ:DRTE)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Dendrite International (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Dendrite International, Inc.